Steven Cohen Repligen Corp Transaction History

Point72 Asset Management, L.P.

$40.1 Billion
Q1 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Repligen Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,116,445 shares of RGEN stock, worth $139 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

1,116,445

Previous 918,623 21.53%

Holding current value

$139 Million

Previous $132 Million 7.43%

% of portfolio

0.35%

Previous 0.31%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$127.24 - $174.24 $25.2 Million - $34.5 Million	197,822 Added 21.53%	1,116,445 $142 Million
Q4 2024 Feb 14, 2025	BUY	$123.41 - $160.92 $73.3 Million - $95.6 Million	594,189 Added 183.15%	918,623 $132 Million
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $1.12 Million - $1.57 Million	9,387 Added 2.98%	324,434 $48.3 Million
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $27.2 Million - $41.4 Million	-226,380 Reduced 41.81%	315,047 $39.7 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $9.47 Million - $11.6 Million	-55,468 Reduced 9.29%	541,427 $99.6 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $68.1 Million - $111 Million	596,895 New	596,895 $107 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $5,675 - $7,392	41 New	41 $5,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $13 Million - $16.7 Million	-84,178 Closed	0 $0
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $36.2 Million - $49.2 Million	-222,926 Reduced 72.59%	84,178 $14.3 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $31.3 Million - $50 Million	-195,237 Reduced 38.87%	307,104 $57.5 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $48.7 Million - $65.1 Million	346,459 Added 222.26%	502,341 $81.6 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $6.96 Million - $11.1 Million	43,191 Added 38.33%	155,882 $29.3 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $8.98 Million - $11 Million	36,278 Added 47.48%	112,691 $29.8 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $62.7 Million - $104 Million	-321,994 Reduced 80.82%	76,413 $22.1 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $9.43 Million - $12.6 Million	56,840 Added 16.64%	398,407 $79.5 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $7.19 Million - $9.01 Million	-39,838 Reduced 10.45%	341,567 $66.4 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $42.3 Million - $59 Million	-285,814 Reduced 42.84%	381,405 $73.1 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $29.4 Million - $37.9 Million	239,625 Added 56.04%	667,219 $98.4 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $39.3 Million - $58.6 Million	416,867 Added 3886.15%	427,594 $52.9 Million
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $6.84 Million - $8.78 Million	-80,478 Reduced 88.24%	10,727 $1.04 Million
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $33.3 Million - $41.9 Million	-450,469 Reduced 83.16%	91,205 $8.44 Million
Q3 2019 Nov 15, 2019	BUY	$76.65 - $95.51 $23.2 Million - $28.9 Million	302,733 Added 126.7%	541,674 $41.5 Million
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $6.56 Million - $10.4 Million	121,028 Added 102.64%	238,941 $20.5 Million
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $184,102 - $233,804	3,723 Added 3.26%	117,913 $6.97 Million
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $9.88 Million - $14.1 Million	-204,710 Reduced 64.19%	114,190 $6.02 Million
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $14.9 Million - $18.8 Million	318,900 New	318,900 $17.7 Million

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

57.6M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.9B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account